SecBot SecBot
3Insider Cluster ·Filed Aug 14, 2026

BLCO

Bausch & Lomb Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001860742-26-000104
Actionable Insight • Neutral

This is a routine initial ownership filing with no trading activity. Monitor future Form 4 filings from Trebbi for any open-market purchases or sales. The separate insider cluster of $988K in sells (VP von Eschenbach and SVP Munsch) may warrant monitoring, but is unrelated to this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$17.00
T+0 close · Aug 14, 2026 · via day close
Latest settled
+25.71%
T+60 · $21.37
Vs SPY
+28.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $17.00entry
  2. T+1 · 3mo ago +0.24%α +0.91% · $17.04
  3. T+5 · 3mo ago +1.88%α +3.07% · $17.32
  4. T+20 · 2mo ago +1.35%α +3.33% · $17.23
  5. T+60 · 7d ago +25.71%α +28.65% · $21.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Barbara Trebbi filed a Form 3 initial statement of beneficial ownership on August 14, 2026, reporting no securities owned. The filing is a routine Section 16 compliance requirement with no trading activity or material financial impact.

Key Facts

  • Barbara Trebbi filed a Form 3 initial statement of beneficial ownership on 2026-08-14
  • The filing discloses no securities owned by the reporting person
  • The filing includes a standard power of attorney authorizing designees to execute Section 16 filings
  • The insider cluster (2 insiders, $988K net sell) occurred in the same window but involves separate individuals

Financial Impact

No financial impact from this filing

Risk Factors

  • No risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
56% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (BLCO), Batch item 10001860742-26-000104
Document: 0001860742-26-000104-index-headers.htmlcluster-BLCO-1786744880836
Document: 0001860742-26-000104-index.html0001860742-26-000104
Document: 0001860742-26-000104.txt0001860742-26-000104
CLUSTER Data (Synthetic)0001860742-26-000104

Track record

24 reports on BLCO

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +16.89% at T+20 after the Oct 1, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $21.14 Now $20.88 −1.23% settles Nov 19
  2. Nov 3, 202613d ago 144 Neutral 2/10 Entry $20.03 to $21.37 Now $20.88 +4.24% ▲ +6.69% +7.28% vs SPY
  3. Oct 29, 202618d ago 144 Neutral 3/10 Entry $20.00 to $19.99 Now $20.88 +4.40% ▼ −0.05% +2.65% vs SPY
  4. Oct 28, 202619d ago 8-K Neutral 2/10 Entry $20.40 to $19.92 Now $20.88 +2.35% ▼ −2.35% +2.37% vs SPY
  5. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $20.40 to $20.60 Now $20.88 +2.35% ▲ +0.98% +1.69% vs SPY
  6. Oct 13, 20264w ago 8-K Mixed 6/10 Entry $15.81 to $16.93 Now $20.88 +32.07% ▲ +7.08% +8.24% vs SPY
  7. Oct 1, 20266w ago Court Ruling Bullish 4/10 Entry $17.11 to $17.30 Now $20.88 +22.03% ▲ +1.11% −0.05% vs SPY
  8. Sep 28, 20267w ago 144 Neutral 2/10 Entry $16.95 to $17.17 Now $20.88 +23.19% ▲ +1.30% +0.09% vs SPY
  9. Aug 14, 202613w ago 3 / CLUSTER Neutral 2/10 Viewing Entry $17.00 to $17.32 Now $20.88 +22.82% ▲ +1.88% +3.07% vs SPY
  10. Aug 14, 202613w ago 3 Neutral 2/10 Entry $17.00 to $17.32 Now $20.88 +22.82% ▲ +1.88% +3.07% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026